Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous subcutaneous hydrocortisone infusion in congenital adrenal hyperplasia
2011-005822-23Phase 2Completed
- Sponsor
- Haukeland University Hospital
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydrocortisone in congenital adrenal hyperplasia (CAH), sponsored by Haukeland University Hospital. Primary endpoint: Androgen levels. Started Feb 2013; status: completed.
02
Drugs
hydrocortisone
03
Conditions
congenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on 2011-005822-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005822-23.